Pacira BioSciences (PCRX) Non Operating Income (2010 - 2026)

Pacira BioSciences' Non Operating Income history runs 17 years deep, the most recent figure standing at -$1.9 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 128.35% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$15.6 million (down 376.94% YoY), while the FY2025 annual figure was -$6.6 million, down 1674.8% from the prior year.
• Non Operating Income was -$1.9 million for Q1 2026 at Pacira BioSciences, up from -$6.1 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $6.7 million in Q1 2025 to a low of -$25.3 million in Q4 2023.
• Historically, Non Operating Income has averaged -$4.9 million across 5 years, with a median of -$422000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Non Operating Income tumbled 31301.23% in 2023, then surged 4380.0% in 2024.
• A 5-year view of Non Operating Income shows it stood at $81000.0 in 2022, then sank by 31301.23% to -$25.3 million in 2023, then soared by 61.16% to -$9.8 million in 2024, then jumped by 38.14% to -$6.1 million in 2025, then surged by 68.64% to -$1.9 million in 2026.
• The last three Non Operating Income figures came in at -$1.9 million (Q1 2026), -$6.1 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.